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Here  we  examine  the carbapenem  and  metronidazole  resistance  mechanisms  of 640  Bacteroides  strains
reported  in  the  2008–2009  European  antibiotic  susceptibility  survey.  Of the  22  strains  with  elevated
imipenem  minimum  inhibitory  concentrations  (≥4  g/mL),  10 were  cﬁA-positive  and out  of  these 5
carried  activating  insertion  sequence  (IS)  elements  in  the  upstream  regions  of the  cﬁA  genes. How-ntibiotic resistance mechanisms
acteroides fragilis
ﬁA
im
nsertion sequence (IS) elements
ever,  resistant  strains  with  cﬁA  genes  but with  no activating  IS elements  were  found  (n  =  2) as  well  as
a resistant  strain  with  no  cﬁA  gene.  In  the  former  the  resistance  phenotypes  by Etest  were  heteroge-
neous,  whilst  in the  latter  no  carbapenemase  production  was  seen;  both  mechanisms  have  been  rarely
observed,  examined  and  characterised.  Interestingly,  few  (n =  3)  nim-positive  strains  were  found,  includ-
ing one  metronidazole-resistant  strain  harbouring  nimE  activated  by  ISBf6,  and two  susceptible  strains
harbouring  chromosomally  located  nim  genes.
lsevie© 2012 E
. Introduction
Bacteroides spp. represent one of the most signiﬁcant groups
f anaerobic bacteria. They are important constituents of the
ntestinal microbiota, from where they can cause severe anaerobic
nfections ranging from those of the soft tissue and upper respi-
atory tract to sepsis and various abscesses [1].  Bacteroides spp.
an harbour the highest number of antibiotic resistance mech-
nisms and have the highest antibiotic resistance prevalences
mong all pathogenic anaerobes [2].  Because of their special and
sually long culture requirements, temporary records of antibiotic
esistance rates is considered a good and recommended practice
orldwide. Such monitoring was performed mostly in the USA [3]
nd Europe [4],  the latter under the organisation of the European
ociety of Clinical Microbiology and Infectious Diseases (ESCMID)Please cite this article in press as: Sóki J, et al. Molecular 
mechanisms of Bacteroides strains reported in a Europe-wide a
http://dx.doi.org/10.1016/j.ijantimicag.2012.10.001
tudy Group for Antimicrobial Resistance in Anaerobic Bacteria
ESGARAB), whose name was changed to the ESCMID Study Group
n Anaerobic Infections to cover a broader interest. The general
∗ Corresponding author. Tel.: +36 62 545 712; fax: +36 62 545 712.
E-mail address: soki.jozsef@med.u-szeged.hu (J. Sóki).
1 ESCMID Study Group on Anaerobic Infections: Denis Piérard, Youri Glupczynski,
laire Nonhoff, Margareta Ieven (Belgium); Smilja Kalenicˇ (Croatia); Eva Chmelarˇova
Czech Republic); Eija Können (Finland); Laurent Calvet, Luc Dubreuil (France);
rika Dósa (Germany); Joseph Papaparaskevas (Greece); Lenke Szikra, Cecilia Mis-
ti, Gabriella Terhes (Hungary); Annarita Mazzariol (Italy); Jordi Vila (Spain); Maria
edberg (Sweden); John Degener, Linda Wildeboer-Veloo (The Netherlands); and
ezhat Güler, Sabiha Güner, Nurver Ulger (Turkey).
924-8579/$ – see front matter ©  2012 Elsevier B.V. and the International Society of Chem
ttp://dx.doi.org/10.1016/j.ijantimicag.2012.10.001r B.V. and the International Society of Chemotherapy. All rights reserved.
trend is almost 100% resistance to penicillins, cephalosporins and
tetracycline, a rising moderate resistance prevalence to cefox-
itin, clindamycin and moxiﬂoxacin, and very low prevalences for
carbapenems, -lactam/-lactamase combinations, metronidazole
and tigecycline [3,4]. Following antibiotic resistance monitoring
for Bacteroides in 2000, molecular analyses were carried out to
determine the metronidazole and carbapenem resistance mech-
anisms [5,6]. These investigations demonstrated the roles of the
nim and cﬁA genes and their activating insertion sequence (IS) ele-
ments in metronidazole and carbapenem resistance mechanisms,
respectively.
Carbapenem-resistant Bacteroides isolates usually belong to the
Bacteroides fragilis group, with the cﬁA resistance gene being chro-
mosomal and the majority of cﬁA-positive strains being susceptible
phenotypically because of the lack of upregulating IS elements
[1]. The best-characterised metronidazole resistance mechanism
among Bacteroides strains is due to the nim genes (nimA–F) that
may  occur in all Bacteroides species, and they are either located
on well-characterised plasmids or on the chromosome. The major-
ity of nim-positive Bacteroides isolates studied harbour a nim
gene and a corresponding IS element pair [6].  It is of interest
that the cﬁA-positive B. fragilis isolates form a subgroup within
this species. The cﬁA-negative and cﬁA-positive strains are there-
fore often classiﬁed as Division I and II, respectively, and cananalysis of the carbapenem and metronidazole resistance
ntibiotic resistance survey. Int J Antimicrob Agents (2012),
be distinguished by differences in DNA–DNA homology rates
and by molecular typing methods such as randomly ampliﬁed
polymorphic DNA polymerase chain reaction (RAPD-PCR), ribo-
typing, multilocus enzyme electrophoresis, sequence typing and
otherapy. All rights reserved.
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Table 1
Primers and PCR conditions originally designed and applied in this study.
PCR Primers Sequence 5′→3′ PCR conditions
cﬁA cﬁA-RT1 AATCGAAGGATGGGGTATGG 95 ◦C for 5 min; 35 cycles of 95 ◦C for 15 s, 59 ◦C for 1 min, 72 ◦C for 30 s; melting 72–95 ◦C
cﬁA-RT2 CGGTCGGTGAATCGGTGAAT
nima nim3 ATGTTCAGAGAAATGCGGCGTAAGCG 95 ◦C for 10 min; 35 cycles of 95 ◦C for 30 s, 62 ◦C for 1 min, 72 ◦C for 1 min; melting 72–95 ◦C
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a The method of Trinh and Reysset was adapted to real-time PCR [13].
atrix-assisted laser-desorption/ionisation time-of-ﬂight (MALDI-
OF) mass spectrometry [7–12]. The Ambler class A cephalospori-
ase gene, cepA, and the enterotoxin bft genes were reported to
ccur exclusively in Division I strains [10].
This study investigated the prevalences of the cﬁA and nim genes,
he imipenem and metronidazole resistance mechanisms in the
ajority of Bacteroides strains reported in the 2008 European Bac-
eroides antibiotic resistance survey.
. Materials and methods
.1. Bacterial strains and cultivation
A total of 640 isolates belonging to the Bacteroides and Parabac-
eroides genera (486 B. fragilis,  54 Bacteroides thetaiotaomicron, 36
acteroides ovatus,  33 Bacteroides vulgatus, 8 Bacteroides uniformis,
 Parabacteroides distasonis,  4 Parabacteroides merdae,  3 Bacteroides
ggerthii, 3 Bacteroides massiliensis, 3 Bacteroides nordii,  2 Bac-
eroides caccae and 1 Bacteroides stercoris) were analysed from the
ollection sent to the central laboratory (Institute of Clinical Micro-
iology, University of Szeged, Szeged, Hungary) for the 2008–2009
uropean Bacteroides antibiotic susceptibility survey (participat-
ng countries: Belgium, Croatia, Czech Republic, Finland, France,
ermany, Greece, Hungary, Italy, Spain, Sweden, The Netherlands
nd Turkey). Isolate identiﬁcation was carried out by routine clin-
cal methods. Strains were stored at −70 ◦C in CryoBank vialsPlease cite this article in press as: Sóki J, et al. Molecular 
mechanisms of Bacteroides strains reported in a Europe-wide a
http://dx.doi.org/10.1016/j.ijantimicag.2012.10.001
Mast Diagnostica, Rheinfeld, Germany) and were cultivated at
7 ◦C anaerobically on Columbia agar supplemented with 5% (v/v)
heep blood, 5 g/L haemin and 1 g/L vitamin K1, or in BHIS broth
brain–heart infusion broth supplemented with 0.5% (w/v) yeast
able 2
nalysis of the imipenem resistance mechanism of strains with elevated imipenem minim
Strain Imipenem MIC  (g/mL) 
Bacteroides fragilis SW42 4 
B. fragilis SW46 4 
B.  fragilis SW83 4 
B.  fragilis TR38 4 
B.  fragilis HU25 4 
B.  fragilis FI63 4 
Bacteroides eggerthii GR67 4 
Bacteroides thetaiotaomicron BEM28 4 
Parabacteroides merdae GR70 4 
B.  fragilis DE14 4 
B.  fragilis HU51 4 
B.  fragilis IT15 4 
Bacteroides stercoris HU59 8 
B.  thetaiotaomicron BEA22 8 
B.  fragilis HU92 8 
B.  fragilis TR27 16 
B.  fragilis TR31 16 
B.  fragilis HU61 32 
B.  fragilis NLH3 >32 
B.  fragilis FR41 >32 
B.  fragilis FI87 >32 
B.  fragilis FI37 >32 
a The effects are not caused by cﬁA.
b The 280-bp PCR fragment displays no insertion upstream of cﬁA.extract, 5 g/L haemin and 1 g/L vitamin K1] in an anaerobic cabi-
net (Concept 400; Ruskinn Technology Ltd., Bridgend, UK) under a
gas composition of 85% N2, 10% H2 and 5% CO2 for 48 h. Antibiotic
resistance results were obtained from the susceptibility measure-
ments done previously by the agar dilution method [4] or by Etest
(bioMérieux, Marcy-l’Étoile, France) as recommended by the sup-
plier. The following control strains were used: B. fragilis TAL3636
(cﬁA); B. fragilis 638R (pIP417) (nimA); B. fragilis BF-8 (nimB); B. frag-
ilis 638R (pIP419) (nimC); B. fragilis 638R (pIP421) (nimD); and B.
fragilis 388 (nimE).
2.2. Real-time PCR detection of the cﬁA and nim genes
Bacterial template DNA samples for the real-time PCR analy-
sis were prepared by incubating 100 L of 0.5 McFarland turbidity
suspensions at 100 ◦C for 10 min, which were stored at −30 ◦C until
use. Real-time PCR experiments were carried out in an MXPro3000
instrument (Stratagene, Santa Clara, CA) with the following reac-
tion setup: 1× MasterMix [iQTM (Bio-Rad Hungary, Budapest,
Hungary) with 1× EvaGreen® (Biotium Inc., Hayward, CA) for nim;
or Brilliant III (Stratagene/Agilent, Santa Clara, CA) for cﬁA and bft],
0.7 M of each primer and 2 L of template DNA preparation in
10 L ﬁnal volumes in 96-well PCR reaction plates. The nucleotide
sequences of the newly used primers and the cycling conditions
chosen during this study are shown in Table 1. Positive reactionsanalysis of the carbapenem and metronidazole resistance
ntibiotic resistance survey. Int J Antimicrob Agents (2012),
were identiﬁed by the starting ampliﬁcation cycle, melting curves
showing the correct melting temperatures, and in rare cases where
it was required to compare the size of the products with those of
the positive controls in 1.2% agarose gel electrophoresis.
um inhibitory concentrations (MICs) (≥4 g/mL).
cﬁA Upstream region Mechanism
− – Othera
− – Other
− – Other
− – Other
− – Other
− – Other
− – Other
− – Other
− – Other
+ 280 bpb Silent with increased MIC
+ 280 bpb Silent with increased MIC
+ IS4351 IS-activated
− – Other
− – Other
+ 280 bpb Silent with increased MIC
+ IS1187 IS-activated
+ IS1187 IS-activated
+ 280 bpb Heteroresistant
+ ISBf11 IS-activated
+ 280 bpb Heteroresistant
+ IS614B IS-activated
− – Other
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.3. Analysis of the carbapenem and metronidazole resistance
echanisms by molecular methods
An analysis of the carbapenem and metronidazole resistance
echanisms was carried out as previously described [14,15].
mipenemase activities were recorded in a 50 mM NaPO4 (pH
.0) buffer using sonicated cell extracts and 0.1 mM imipenem
y following absorbance changes at 299 nm.  Protein concen-
rations were measured with a Quant-iTTM Protein Assay Kit
sing a Qubit® Mini Fluorometer (Life Technologies Hungary Ltd.,
udapest, Hungary). Tazobactam (10 g/mL) or 10 mM ethylene
iamine tetra-acetic acid (EDTA) were used to inhibit the enzymes,
nd imipenemase activity was expressed as 1 nmol hydrolysed
mipenem/min (1 U) standardised by the protein concentration of
he sonicates. Nucleotide sequencing was performed using an auto-
ated sequencer as described previously [15]. The novel nucleotide
equence of ISBf11 was deposited in the GenBank database under
ccession no. GQ449386.
. Results and discussion
.1. Resistance mechanisms of Bacteroides strains with elevated
mipenem minimum inhibitory concentrations (MICs)
Of the 640 Bacteroides strains included in this study, 22 had
mipenem MICs ≥ 4 g/mL. Of the 486 B. fragilis strains examined,
3 were cﬁA-positive, and from the 640 Bacteroides isolates exam-
ned 22 and 7 had imipenem MICs ≥4 g/mL and ≥16 g/mL,
espectively. No non-fragilis Bacteroides strains were resistant
o imipenem and only one cﬁA-negative B. fragilis isolate was
esistant. The results are summarised in Table 2. Of the 10 B. frag-
lis strains with elevated imipenem MICs (4–8 g/mL), 4 (40.0%)
ere cﬁA-positive, whilst 6 (85.7%) of the 7 imipenem-resistant
MIC ≥ 16 g/mL) B. fragilis isolates were cﬁA-positive. Among the
trains with elevated MICs and with cﬁA genes, one harboured
n IS element upstream of cﬁA (B. fragilis IT15), and among the
ﬁA-positive and imipenem-resistant strains four harboured IS ele-
ents upstream of the resistance gene (Table 2). The remaining two
ﬁA-positive isolates that were imipenem-resistant but without
ctivating IS elements upstream of cﬁA displayed a heterogeneous
esistance phenotype using the imipenem Etest (see the example
n Fig. 1).
This study yielded similar prevalence values for the molecular
echanisms of imipenem resistance of B. fragilis strains as those
n previous studies. Among the highly imipenem-resistant strains
MIC ≥ 16 g/mL), the cﬁA genes are activated by IS elements (4 of
 cﬁA-positive), and among strains with elevated imipenem MICs
≥4 g/mL) the cﬁA genes were enriched (26.7% compared with
he commonly found 2–8%). The types of cﬁA-activating IS elements
ere IS1187 (n = 2), IS614B  (n = 1), and a novel IS element (n = ISBf11;
enBank accession no. GQ449386) for B. fragilis H3 that had 77%
omology compared with IS614B  (Table 2). Bacteroides fragilis IT15
arboured IS4351 upstream of the cﬁA gene, but its imipenem MIC
as low (4 g/mL). This latter ﬁnding is in accordance with that of
odglajen et al. [8] who found that B. fragilis strains carrying IS4351
pstream of the cﬁA genes also tended to have low imipenem MICs
16 g/mL) compared with other IS elements (IS942 and IS1186;
ICs ≥ 64 g/mL). Previously we detected a probably low-activity
acteroides promoter-like sequence in the upstream regions of the
ﬁA genes. According to this, our study and other studies detected
levated imipenemase activities in ‘silent’ cﬁA-positive strains thatPlease cite this article in press as: Sóki J, et al. Molecular 
mechanisms of Bacteroides strains reported in a Europe-wide a
http://dx.doi.org/10.1016/j.ijantimicag.2012.10.001
ould account for the imipenem MICs in such strains [14,16]. How-
ver, some highly imipenem-resistant strains (n = 2) were also
enetically silent, their cﬁA genes not being activated by IS ele-
ents (Table 2). In these cases Etest susceptibility tests detectedFig. 1. Heterogeneous imipenem-resistant phenotype of Bacteroides fragilis FR41
detected by Etest. The ﬁrst (0.25 g/mL) and second (4 g/mL) inhibition zones are
marked by thin and thicker arrows, respectively.
heterogeneous resistance phenotypes (Fig. 1) where, inside of con-
ﬂuent inhibition zones, resistant colonies or growth appeared. This
phenomenon can be explained by activation of the cﬁA genes by
an as yet unidentiﬁed mechanism that boosts the carbapenemase
activity of the strains. We previously described such heteroresistant
strains from human faeces whose imipenem MICs and imipene-
mase activities displayed a relation. In contrast, the cﬁA genes were
not activated by IS elements [16]. For Bacteroides, we  detected het-
erogeneously cefoxitin-resistant strains and hypothesised that the
copy number of the corresponding cfxA resistance gene might be
important [17].
A cﬁA-negative but imipenem-resistant B. fragilis isolate was
identiﬁed in this study (B. fragilis FI37; Table 2). Such strains
were also found previously, but the exact carbapenem resistance
mechanism for these strains has not yet been clariﬁed [18,19]. An
imipenemase assay of this strain did not reveal any activity, whilst
the control B. fragilis TAL3636 strain produced 41.0 U/mg imipene-
mase activity that was inhibited by EDTA. The probable resistanceanalysis of the carbapenem and metronidazole resistance
ntibiotic resistance survey. Int J Antimicrob Agents (2012),
mechanisms are penicillin-binding protein (PBP) afﬁnity or perme-
ability changes.
A strain-dependent role for PBPs in the case of eight B. fragilis
strains with various imipenem MICs (0.12–16 g/mL) was reported
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reviously [19], and mutations of an endogenous efﬂux system
bmeABC) also affected the carbapenem susceptibilities of the car-
ying strains [20].
.2. Detection of nim genes and their relation to metronidazole
esistance
Of the 640 Bacteroides strains, 21 had reduced susceptibility
o metronidazole (MIC ≥ 4 g/mL) and only 3 (B. fragilis IT724
nd IT797 and B. thetaiotaomicron HU66) harboured nim genes,
ith the following metronidazole MICs: 0.125 g/mL (B. fragilis
T797), 1 g/mL (B. fragilis IT724) and 256 g/mL (B. thetaio-
aomicron HU66). An examination of the nim-mediated resistance
echanisms revealed that B. fragilis IT797 and IT724 harboured
hromosomal nimA and nimC genes, respectively. By contrast, the
imE gene of B. thetaiotaomicron HU66 was located on an 8.3 kb
pBF388c-like) [15] plasmid and was activated by ISBf6 (data not
hown). No nim-speciﬁc plasmids were detected in the two other
trains (a 5.6 kb class III plasmid and no plasmid content were
haracteristic for B. fragilis IT797 and IT724, respectively). Fur-
hermore, B. fragilis IT797 harboured IS1168 and IS1170, but these
lements could not be mapped to the nimA gene by PCR mapping.
rom these results, it appears that the situation with nim-mediated
etronidazole-resistant Bacteroides strains has changed in Europe
ompared with the previous study where 43 Bacteroides strains
ith reduced metronidazole susceptibility (MICs ≥ 4 g/mL; 3.3%)
nd 30 (2.0%) nim-positive strains were found [6].  The current sit-
ation in Europe is reminiscent of that in the USA where nim genes
nd metronidazole resistances were scarce for a long time [21].
he nim-negative but metronidazole-resistant Bacteroides strains
ound in the current study may  have other resistance mecha-
isms (reduced uptake, nitroreductase and pyruvate–ferredoxin
xidoreductase activities, increased lactate dehydrogenase activ-
ty, or mutations that alter the carbohydrate utilisation affecting
he redox state) which shortcut the detrimental cellular effects of
his drug [2,22–24].
In conclusion, these results conﬁrmed the present view of car-
apenem and metronidazole resistance mechanisms of Bacteroides
pp. but also provide new information regarding their current state
nd epidemiology in Europe in addition to newly described mecha-
isms such as non-carbapenemase-mediated imipenem resistance
nd chromosomal nim genes.
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